Skip to main content
Orchid Pharma Limited logo

Orchid Pharma Limited — Investor Relations & Filings

Ticker · ORCHPHARMA ISIN · INE191A01027 LEI · 33580076KIKCYSLZVF05 BSE.NS Manufacturing
Open in API
Filings indexed 448 across all filing types
Latest filing 2025-02-12 Regulatory Filings
Country IN India
Listing BSE.NS ORCHPHARMA

About Orchid Pharma Limited

https://www.orchidpharma.com/

Orchid Pharma Limited is a vertically integrated organization focused on the development, manufacture, and marketing of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). The company specializes in the anti-infectives segment, with a particular emphasis on cephalosporins and penicillins. Its operations span the entire value chain, including advanced research and development, process chemistry, and large-scale manufacturing. Orchid Pharma maintains facilities that adhere to rigorous international regulatory standards, enabling the supply of high-quality generic formulations and complex molecules to global markets. The company prioritizes innovation in chemical synthesis and formulation development to address complex therapeutic requirements and enhance healthcare outcomes through a robust portfolio of essential medicines.

Recent filings

Filing Released Lang Actions
Integrated Filing- Financial
Regulatory Filings
2025-02-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is an investor presentation dated February 12, 2025, for the quarter ended December 31, 2024 (Q3 FY 2024-25). It includes detailed financial performance data such as sales, EBITDA, PBT, PAT, and segment financials. The text references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates disclosure of material information including investor presentations. The document is not a full annual or quarterly report but a presentation summarizing financial results and business highlights for investors. It is not a brief announcement or a certification letter but a detailed presentation with charts and financial tables. Therefore, the appropriate classification is Investor Presentation (IP).
2025-02-12 English
Outcome of Board Meeting
Regulatory Filings
2025-02-12 English
Financial Result Updates
Interim / Quarterly Report Classification · 95% confidence The document is an Independent Auditor's Review Report on the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024, prepared pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It references Indian Accounting Standard 34 (Interim Financial Reporting) and includes detailed auditor commentary, scope, and emphasis of matter. The document contains substantive financial data and analysis for an interim period shorter than a full fiscal year. It is not merely an announcement or certification but a full auditor's review report on interim financial results. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2025
2025-02-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation regarding the schedule of an Analysts/Investors Earnings Call for the quarter ended December 31, 2024. It references the upcoming earnings call event, provides dial-in details, and invites participation. There is no actual financial data or results disclosed in this document; it is purely an announcement of the earnings call. According to the classification rules, announcements about earnings calls or their schedules are not the earnings release itself but rather a notification. The document length is under 5,000 characters and it does not contain financial results, so it is not an Earnings Release (ER). Instead, it is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the earnings call schedule under SEBI regulations, and does not fit other categories more specifically.
2025-02-06 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-02-06 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.